Trials / Completed
CompletedNCT04534309
Behavioral Weight Loss Program for Cancer Survivors in Maryland
Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 340 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project
Detailed description
The objective of the ASPIRE Project is to design, implement, and evaluate a real-world, lifestyle-based, support for overweight or obese cancer survivors in both urban and rural areas of Maryland. The project will provide three options of support to encourage lifestyle change to achieve and maintain a healthy weight for cancer survivors: 1. Self-Directed Weight Loss: educational materials only; 2. App-Directed Weight Loss: educational materials, weight loss app with weekly e-mail support; and 3. Coach-Directed Weight Loss: educational materials, weight loss app, weekly e-mail support and one-to-one weekly telephonic coach support.
Conditions
- Breast Cancer
- Prostate Cancer
- Melanoma (Skin)
- Endometrial Cancer
- Gallbladder Cancer
- Rectal Cancer
- Kidney Cancer
- Bladder Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Written Weight Loss Material | Participants will receive written weight loss material by email. |
| BEHAVIORAL | Weight Loss App | Participants will receive written weight loss material as well as instructions for using a free weight loss app on their phone or computer. |
| BEHAVIORAL | Behavioral Lifestyle Weight Loss Intervention (Coaching) | Participants will receive weekly coaching phone calls to encourage regular dietary, exercise, and self-monitoring practices which encourage gradual, healthy weight loss. |
Timeline
- Start date
- 2020-09-22
- Primary completion
- 2022-12-15
- Completion
- 2023-06-30
- First posted
- 2020-09-01
- Last updated
- 2023-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04534309. Inclusion in this directory is not an endorsement.